引用次数
引用: 6,062
H-指数: 28
I10-指数 : 36
出版物: 83
S.17.02 The role of melatonin in the treatment of ASD
R. Frye , D.A. Rossignol
European Neuropsychopharmacology 25
2015
Environmental toxicants and autism spectrum disorders: a systematic review
D A Rossignol , S J Genuis , R E Frye
Translational Psychiatry 4 ( 2)
460
2014
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
D A Rossignol , R E Frye
Molecular Psychiatry 17 ( 3) 290 -314
779
2012
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.
D A Rossignol , R E Frye
Molecular Psychiatry 17 ( 4) 389 -401
575
2012
Cerebral folate receptor autoantibodies in autism spectrum disorder
R E Frye , J M Sequeira , E V Quadros , S J James
Molecular Psychiatry 18 ( 3) 369 -381
142
2013
Melatonin in autism spectrum disorders: a systematic review and meta-analysis.
DANIEL A ROSSIGNOL , RICHARD E FRYE
Developmental Medicine & Child Neurology 53 ( 9) 783 -792
255
2011
Mitochondrial Dysfunction Can Connect the Diverse Medical Symptoms Associated With Autism Spectrum Disorders
RICHARD E. FRYE , DANIEL A. ROSSIGNOL
Pediatric Research 69 ( 8) 41 -47
232
2011
Cerebral Folate Deficiency in Autism Spectrum Disorders
RICHARD E FRyE , DANIEL A ROSSIgNOL
Autism Sci. Dig. J. Autsmone
1
2011
The Folate Factor
DAN ROSSIGNOL , RICHARD FRYE
Novel and emerging treatments for autism spectrum disorders: a systematic review.
Daniel A Rossignol
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 21 ( 4) 213 -236
130
2009
Autism spectrum disorders: rising prevalence drives research on causes and cures.
Daniel A Rossignol , Sanjay Gupta
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 21 ( 4) 193
1
2009
A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.
Richard E Frye , Daniel A Rossignol
Journal of Personalized Medicine 11 ( 6)
16
2021
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
Daniel A Rossignol , Lanier W Rossignol , S Jill James , Stepan Melnyk
BMC Pediatrics 7 ( 1) 36 -36
85
2007
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
Daniel A Rossignol , Lanier W Rossignol , Scott Smith , Cindy Schneider
BMC Pediatrics 9 ( 1) 21 -21
76
2009
Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis
Daniel A Rossignol ,
Medical gas research 2 ( 1) 6 -6
32
2012
Hyperbaric oxygen treatment in autism spectrum disorders
Daniel A Rossignol , James J Bradstreet , Kyle Van Dyke , Cindy Schneider
Medical gas research 2 ( 1) 16 -16
30
2012
Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (folinic acid) treatment in autism spectrum disorders: a systematic review and meta-analysis
Daniel A Rossignol , Richard E Frye
Journal of personalized medicine 11 ( 11) 1141
20
2021
The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder
Neluwa-Liyanage R Indika , Richard E Frye , Daniel A Rossignol , Susan C Owens
Journal of Personalized Medicine 13 ( 2) 252
2023
Psychotropic Medications for Sleep Disorders in Autism Spectrum Disorders
Daniel A Rossignol , Richard E Frye ,
Springer International Publishing 1191 -1217
8
2022
Ratings of the effectiveness of nutraceuticals for autism spectrum disorders: results of a national survey
James B Adams , Anisha Bhargava , Devon M Coleman , Richard E Frye
Journal of Personalized Medicine 11 ( 9) 878 -878
17
2021